2020
$265M
from 21 investors over 21 rounds
Sonoma Biotherapeutics raised $30M on March 28, 2023
Investors: Regeneron
Sonoma Biotherapeutics raised $265M on August 4, 2021
Investors: NS Investment, Lilly Asia Ventures, Octagon Capital, Piper Sandler, JDRF T1D Fund, Osage University Partners (OUP), Lifeforce Capital, Mirae Asset MAPS Global Investments Co., Ltd and Vertex Ventures HC
Sonoma Biotherapeutics raised $30M on September 30, 2020
Investors: Octagon Capital, Lilly Asia Ventures, Lyell Immunopharma, JDRF T1D Fund, Lifeforce Capital, 8VC and ARCH Venture Partners
Sonoma Biotherapeutics raised $40M on February 6, 2020
Investors: Lyell Immunopharma, 8VC, Milky Way Ventures and ARCH Venture Partners